Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, August 17, 2020

Neurological Deterioration in Patients with Acute Ischemic Stroke or Transient Ischemic Attack

Well fuck, the proper thing to do is CREATE EXACT STROKE PROTOCOLS THAT STOP THIS NEUROLOGICAL DETERIORATION. Isn't this just stating the obvious?

Like maybe stopping the 5 causes of the neuronal cascade of death in the first week, allowing billions of neurons to die.

The latest here:

Neurological Deterioration in Patients with Acute Ischemic Stroke or Transient Ischemic Attack

Tai Hwan Park, Jeong-Kon Lee, Moo-Seok Park, Sang-Soon Park, Keun-Sik Hong, Wi-Sun Ryu, Dong-Eog Kim, Man Seok Park, Kang-Ho Choi, Joon-Tae Kim, Jihoon Kang, Beom Joon Kim, Moon-Ku Han, Jun Lee, Jae-Kwan Cha, Dae-Hyun Kim, Jae Guk Kim, Soo Joo Lee, Yong-Jin Cho, Jee-Hyun Kwon, Dong-Ick Shin, Min-Ju Yeo, Sung Il Sohn, Jeong-Ho Hong, Ji Sung Lee, Jay Chol Choi, Wook-Joo Kim, Byung-Chul Lee, Kyung-Ho Yu, Mi-Sun Oh, Jong-Moo Park, Kyusik Kang, Kyung Bok Lee, Juneyoung Lee, Philip B. Gorelick, Hee-Joon Bae

Abstract

Objective: To improve epidemiological knowledge of neurological deterioration (ND) in patients with acute ischemic stroke (AIS)

Methods: In this prospective observational study, we captured ND prospectively in 29,446 AIS patients admitted to 15 hospitals in Korea within 7 days of stroke onset. ND was defined as an increase in National Institutes of Health Stroke Scale (NIHSS) score ≥2 (total), or ≥1 (motor or consciousness), or any new neurological symptoms. Change of incidence rate after stroke onset, causes, factors associated with ND, modified Rankin Scale (mRS) at 3 months and 1 year, and a composite of stroke, myocardial infarction and all-cause death at 1 year were assessed.

Results: ND occurred in 4299 (14.6%) patients. The highest rate, 6.95 per 1,000 person-hours incidence was within the first 6 hours which decreased to 2.09 within 24-48 hours, and 0.66 within 72-96 hours after stroke onset. Old age, women, diabetes, early arrival, large artery atherosclerosis as a stroke subtype, high NIHSS scores, glucose level, systolic blood pressure, leukocytosis at admission, recanalization therapy, transient ischemic attack without a relevant lesion, steno-occlusion of relevant arteries were associated with ND. The causes were stroke progression (71.8%), followed by recurrence (8.5%). Adjusted relative risks (95% confidence interval) for poor outcome (mRS 3-6) at 3 months and one year were 1.75 (1.70-1.80), and 1.70 (1.65-1.75), respectively. The adjusted hazard ratio (95% confidence interval) for the composite event was 1.59 (1.45-1.74).

Conclusions: ND should be taken into consideration as a factor that may influence the outcome in acute ischemic stroke.

  • Received October 15, 2019.
  • Accepted in final form April 27, 2020.
 

No comments:

Post a Comment